SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TGTX has rallied to a fresh 52-week high amid anticipation of its Q3 results, with traders also debating whether the move reflects BRIUMVI growth and momentum or speculative buyout and short-covering activity. The earnings date remains unconfirmed, and the company has not confirmed acquisition rumors.

Albemarle Corp. engages in the development, manufacture, and marketing of chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, transportation, pharmaceuticals, crop production, food-safety, and custom chemistry services. It operates through the following segments: Energy Storage, Specialties, and Ketjen. The Energy Storage segment develops and manufactures a broad range of basic lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride. The Specialties segment focuses on optimizing a portfolio of bromine and specialized lithium solutions. The Ketjen segment consists of clean fuels technologies, fluidized catalytic cracking catalysts and additives, and performance catalyst solutions, which is primarily composed of organometallics and curatives. The company was founded in 1993 and is headquartered in Charlotte, NC.

Albemarle Corp.

Albemarle Corp

Albemarle is under pressure amid falling lithium spot and futures prices, with traders concerned about the impact on earnings and guidance. The community is split between expecting more downside and viewing the selloff as a buying opportunity, citing longer-term EV and energy-storage demand.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

CVS is drawing attention over weaker Aetna Medicare Advantage star ratings for 2027, which traders say could reduce quality-bonus revenue and pressure margins. The outlook is debated, with some viewing the ratings decline as a headwind while others question whether the risk is already reflected in the shares.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

Fubos steep, volatile decline and repeated lowsoften described by traders as happening without clear company-specific newsdominate the discussion, with attention focused on earnings and CEO Alisa Bowens strategic plan. Bearish traders cite business and dilution concerns, while bulls point to potential Disney/Hulu integration progress and speculate about a rebound or short covering.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Updated NSCLC trial results and Iovances move toward biomarker-selected patient groups are driving attention: the overall response rate held near prior levels, while a retrospective subgroup showed a stronger signal, but durability and regulatory implications remain uncertain. Traders are split between viewing the subgroup strategy as promising and seeing a narrower, later lung opportunity, with frustration over the datas presentation and the sharp selloff ahead of earnings.

CleanSpark, Inc. is a bitcoin mining technology company, which engages in the management of data centers. Its operations include College Park, Norcross, Washington, Sandersville, Dalton, and Massena. The company was founded by S. Matthew Schultz and Bryan Huber on October 15, 1987 and is headquartered in Henderson, NV.

Cleanspark Inc

A steep selloff in CleanSpark and other bitcoin-mining and data-center stocks is dominating discussion, with traders citing sector weakness, debt and interest-rate concerns, and CLSKs lagging performance despite comparatively resilient bitcoin prices. Bulls point to the Meta data-center lease and the companys bitcoin holdings, while bears remain focused on leverage, management, and continued downside.

Solana (SOL) is a cryptocurrency launched in 2020. Solana has a current supply of 636,700,074.15773964 with 590,039,678.80449963 in circulation. The last known price of Solana is 96.1784535 USD and is up 0.49 over the last 24 hours. It is currently trading on 1189 active market(s) with $4,706,478,769.37 traded over the last 24 hours. More information can be found at https://solana.com.

Solana

Traders are focused on an alleged Binance security incident and concern that withdrawal problems or customer selling could add pressure across crypto, including Solana. The reaction is split between bearish warnings and traders treating the decline as a buying opportunity, with many saying they are accumulating and staking.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsofts quarterly results and accelerating Azure growth fueled optimism about AI demand, but the post-earnings rally faded as traders weighed plans to fund its AI buildout with debt and questioned the returns on rising infrastructure spending. The debate is whether strong cloud growth and cash generation can outweigh financing concerns and broader weakness in big tech.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Strategy shares are under pressure as Bitcoin and crypto-linked stocks sell off amid reports of a major Binance security breach; traders are split between buying the dip and warning that the incident could deepen crypto-market concerns. Q3 results and the CFO transition also draw scrutiny, with bears questioning the quality of reported earnings and bulls emphasizing the companys Bitcoin exposure.

Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.

Celcuity Inc

Attention centers on updated Phase 3 VIKTORIA-1 data for gedatolisib in PIK3CA-mutant breast cancer, with traders highlighting the favorable progression-free-survival and response results and the pending FDA review of a label expansion. The community is split between optimism about the drugs clinical potential and concern that commercial uptake and revenue execution still need to validate the story.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Oil ETFs to Benefit as Oil Prices Rally Due to Geopolitical Tensions

Oil prices top $110 amid Middle East tensions and falling U.S. inventories. Explore BNO, XLE and OIH as supply risks shape the outlook for oil ETFs.

Energy ETFs to Watch as Bond Market Carnage Shows Signs of Cooling  

Energy ETFs are gaining as bond-market turmoil cools, with high oil prices supporting energy stocks while yield stabilization could lift sentiment.

Dollar Strengthens on Oil Surge & Hawkish Fed Policy: ETFs to Benefit

Rising oil prices and hawkish Fed policy are supporting the dollar, putting currency and energy ETFs in focus.

OPEC+ Keeps October Output Same: Oil ETFs in Focus

OPEC+ holds October output steady as Iran tensions tighten oil supply. What's next for oil prices and ETFs?

Should You Invest in the VanEck Oil Services ETF (OIH)?

Energy ETFs to Watch as US-Venezuela Sign Historic Oil Deal

Energy ETFs could benefit as the U.S.-Venezuela oil deal drives long-term investment in Venezuela's oil infrastructure.

Geopolitical Risks Lift Oil Prices: 4 ETFs to Watch

Oil prices rebound as fading U.S.-Iran diplomacy, and supply risks in the Strait of Hormuz and Russia revive the case for oil-focused ETFs.

U.S. SPR Falls Fast: What Does it Mean for Oil & Energy ETFs?

The U.S. SPR falls below 300M million barrels. Could shrinking reserves and oil-supply risks reshape the outlook for oil and energy ETFs?

Here's How SLB's Q2 Earnings Impact Energy ETFs

Schlumberger beats Q2 earnings and revenue estimates, lifting investor interest in energy ETFs like IEZ, OIH and XLE with heavy exposure to SLB.

The Zacks Analyst Blog Highlights BNO, USO, XLE, IEO, OIH, and DBO

BNO surged as Hormuz tensions lifted oil prices, while the blog explores why energy ETFs could benefit???and the risks if the conflict eases.

VanEck ETF Trust - VanEck Oil Services ETF

Transocean Is Cashing In On Crude Oil’s War-Driven Surge

Equity

Neutral Sentiment

<ul class="summary-bullets"><li>Transocean stated that its Norway offshore rig contract is worth $490 million, accounting for about half of the company’s $1 billion deal wins.</li><li>The company also secured a 1,095-day extension from Petrobras in Brazil for its Deepwater Orion offshore rig, with the deal valued at $420 million.</li><li>Petrobras also extended Transocean’s Deepwater Aquila rig’s operations by 365 days, contributing about $160 million in order backlog.</li></ul>Transocean (RIG) shares gained nearly 5% in Thursday’s pre-market trade after the company announced major contract wins amid soaring crude oil prices.Transocean announced that it has secured contracts worth $1 billion for three offshore rigs, one in Norway and two in Brazil.The company’s massive deal wins come at a time when crude oil prices are soaring amid the ongoing Iran war, and President Donald Trump’s national address on Wednesday failed to signal a clear end to the conflict.U.S. West Texas Intermediate (WTI) crude futures maturing in May gained nearly 8% to hover around $108 per barrel. Brent crude futures expiring in June surged 7% to $109 per barrel.The&nbsp;<a href="https://stocktwits.com/symbol/USO">United States Oil Fund ETF</a> (USO) and the&nbsp;<a href="https://stocktwits.com/symbol/UCO">ProShares Ultra Bloomberg Crude Oil ETF</a> (UCO) were up about 8% at the time of writing.<h2 class="st-heading-2">Norway Contract Worth Half Of Transocean’s Wins</h2>Transocean stated that its Norway offshore rig contract is worth $490 million, accounting for about half of the company’s $1 billion deal wins.The company said it has been awarded a 1,905-day contract with Vår Energi ASA, with the program expected to commence in the second quarter of 2027. Transocean added that the contract has options that could extend the rig’s operations into 2034, if its customer fully exercises those options.Transocean also secured a 1,095-day extension from Petrobras in Brazil for its Deepwater Orion offshore rig. This deal brings $420 million in order backlog and commits the rig’s operations through March 2030.Lastly, Petrobras also extended Transocean’s Deepwater Aquila rig’s operations by 365 days, contributing about $160 million in order backlog.The company also stated that it retired the 8.375% Senior Secured Notes due 2028 in full, settling the outstanding principal of $358 million and other dues in cash.<h2 class="st-heading-2">Here’s Why Rising Crude Prices Are A Tailwind For Offshore Rigs</h2>Higher crude oil prices increase the profitability of deepwater projects, which are capital-intensive, leading to higher demand for rigs.During sustained high oil prices, companies invest offshore to lock in future supply, not just short-term gains.Crude oil prices have risen by about 92% in 2026 so far, with nearly 55% of the surge coming over the last month amid the ongoing Iran war.<a href="https://stocktwits.com/symbol/RIG">RIG stock</a> is up 57% year-to-date and 96% over the past 12 months. The Invesco Oil &amp; Gas Services ETF (PXJ) is up 57% over the past 12 months, while the VanEck Oil Services ETF (OIH) is up 49%.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/tesla-china-made-ev-sales-march-2026/cZ7xoOYRI8R">Tesla’s China-Made EV Sales Rise 9% In March, Registering Fifth Straight Month Of Gains: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

 In this photo illustration, the Transocean company logo is seen displayed on a smartphone screen. (Photo Illustration by Piotr Swat/SOPA Images/LightRocket via Getty Images)

Transocean (RIG Stock) announced that it has secured contracts worth $1 billion for three offshore rigs, one in Norway and two in Brazil.

Transocean (RIG) Is Cashing In On Crude Oil’s War-Driven Surge

Transocean announced that it has secured contracts worth $1 billion for three offshore rigs, one in Norway and two in Brazil.

VanEck Oil Services ETF

Invesco Oil & Gas Services ETF

Transocean Ltd

ProShares Ultra Bloomberg Crude Oil

United States Oil Fund

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$411.57
Prev Close	$407.90
Open	$406.78
Dividend Yield	N/A
50-Day Moving Average	$401.16
Beta	N/A
Avg. Volume	254,422.47
PE Ratio	N/A

52-Week High	$459.28
52-Week Low	$270.55
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

OIH Fundamentals